298 related articles for article (PubMed ID: 27756455)
1. Studies of the Transmission Dynamics, Mathematical Model Development and the Control of Schistosome Parasites by Mass Drug Administration in Human Communities.
Anderson RM; Turner HC; Farrell SH; Truscott JE
Adv Parasitol; 2016; 94():199-246. PubMed ID: 27756455
[TBL] [Abstract][Full Text] [Related]
2. What is required in terms of mass drug administration to interrupt the transmission of schistosome parasites in regions of endemic infection?
Anderson RM; Turner HC; Farrell SH; Yang J; Truscott JE
Parasit Vectors; 2015 Oct; 8():553. PubMed ID: 26489831
[TBL] [Abstract][Full Text] [Related]
3. Impact of Schistosoma mansoni on malaria transmission in Sub-Saharan Africa.
Ndeffo Mbah ML; Skrip L; Greenhalgh S; Hotez P; Galvani AP
PLoS Negl Trop Dis; 2014 Oct; 8(10):e3234. PubMed ID: 25329403
[TBL] [Abstract][Full Text] [Related]
4. Moving from control to elimination of schistosomiasis in sub-Saharan Africa: time to change and adapt strategies.
Tchuem Tchuenté LA; Rollinson D; Stothard JR; Molyneux D
Infect Dis Poverty; 2017 Feb; 6(1):42. PubMed ID: 28219412
[TBL] [Abstract][Full Text] [Related]
5. Modelling the effects of mass drug administration on the molecular epidemiology of schistosomes.
Lamberton PH; Crellen T; Cotton JA; Webster JP
Adv Parasitol; 2015 Mar; 87():293-327. PubMed ID: 25765198
[TBL] [Abstract][Full Text] [Related]
6. Human schistosomiasis in the post mass drug administration era.
Mutapi F; Maizels R; Fenwick A; Woolhouse M
Lancet Infect Dis; 2017 Feb; 17(2):e42-e48. PubMed ID: 27988094
[TBL] [Abstract][Full Text] [Related]
7. Diagnostics for schistosomiasis in Africa and Arabia: a review of present options in control and future needs for elimination.
Stothard JR; Stanton MC; Bustinduy AL; Sousa-Figueiredo JC; Van Dam GJ; Betson M; Waterhouse D; Ward S; Allan F; Hassan AA; Al-Helal MA; Memish ZA; Rollinson D
Parasitology; 2014 Dec; 141(14):1947-61. PubMed ID: 25158604
[TBL] [Abstract][Full Text] [Related]
8. Core components, concepts and strategies for parasitic and vector-borne disease elimination with a focus on schistosomiasis: A landscape analysis.
Monnier N; Barth-Jaeggi T; Knopp S; Steinmann P
PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008837. PubMed ID: 33125375
[TBL] [Abstract][Full Text] [Related]
9. Schistosomiasis in infants and pre-school-aged children in sub-Saharan Africa: implication for control.
Ekpo UF; Oluwole AS; Abe EM; Etta HE; Olamiju F; Mafiana CF
Parasitology; 2012 Jun; 139(7):835-41. PubMed ID: 22313588
[TBL] [Abstract][Full Text] [Related]
10. Parasite Population Genetic Contributions to the Schistosomiasis Consortium for Operational Research and Evaluation within Sub-Saharan Africa.
Webster JP; Neves MI; Webster BL; Pennance T; Rabone M; Gouvras AN; Allan F; Walker M; Rollinson D
Am J Trop Med Hyg; 2020 Jul; 103(1_Suppl):80-91. PubMed ID: 32400355
[TBL] [Abstract][Full Text] [Related]
11. A comparison of two mathematical models of the impact of mass drug administration on the transmission and control of schistosomiasis.
Truscott JE; Gurarie D; Alsallaq R; Toor J; Yoon N; Farrell SH; Turner HC; Phillips AE; Aurelio HO; Ferro J; King CH; Anderson RM
Epidemics; 2017 Mar; 18():29-37. PubMed ID: 28279453
[TBL] [Abstract][Full Text] [Related]
12. Estimating the elimination feasibility in the 'end game' of control efforts for parasites subjected to regular mass drug administration: Methods and their application to schistosomiasis.
Arakala A; Hoover CM; Marshall JM; Sokolow SH; De Leo GA; Rohr JR; Remais JV; Gambhir M
PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006794. PubMed ID: 30418968
[TBL] [Abstract][Full Text] [Related]
13. The Effect of Climate Change and the Snail-Schistosome Cycle in Transmission and Bio-Control of Schistosomiasis in Sub-Saharan Africa.
Adekiya TA; Aruleba RT; Oyinloye BE; Okosun KO; Kappo AP
Int J Environ Res Public Health; 2019 Dec; 17(1):. PubMed ID: 31887979
[TBL] [Abstract][Full Text] [Related]
14. Are We on Our Way to Achieving the 2020 Goals for Schistosomiasis Morbidity Control Using Current World Health Organization Guidelines?
Toor J; Alsallaq R; Truscott JE; Turner HC; Werkman M; Gurarie D; King CH; Anderson RM
Clin Infect Dis; 2018 Jun; 66(suppl_4):S245-S252. PubMed ID: 29860290
[TBL] [Abstract][Full Text] [Related]
15. Modelling control of Schistosoma haematobium infection: predictions of the long-term impact of mass drug administration in Africa.
Gurarie D; Yoon N; Li E; Ndeffo-Mbah M; Durham D; Phillips AE; Aurelio HO; Ferro J; Galvani AP; King CH
Parasit Vectors; 2015 Oct; 8():529. PubMed ID: 26489408
[TBL] [Abstract][Full Text] [Related]
16. Time to set the agenda for schistosomiasis elimination.
Rollinson D; Knopp S; Levitz S; Stothard JR; Tchuem Tchuenté LA; Garba A; Mohammed KA; Schur N; Person B; Colley DG; Utzinger J
Acta Trop; 2013 Nov; 128(2):423-40. PubMed ID: 22580511
[TBL] [Abstract][Full Text] [Related]
17. Towards control of schistosomiasis in sub-Saharan Africa.
Southgate VR; Rollinson D; Tchuem Tchuenté LA; Hagan P
J Helminthol; 2005 Sep; 79(3):181-5. PubMed ID: 16153310
[TBL] [Abstract][Full Text] [Related]
18. Factors affecting the uptake of preventive chemotherapy treatment for schistosomiasis in Sub-Saharan Africa: A systematic review.
Torres-Vitolas CA; Dhanani N; Fleming FM
PLoS Negl Trop Dis; 2021 Jan; 15(1):e0009017. PubMed ID: 33465076
[TBL] [Abstract][Full Text] [Related]
19. Refined stratified-worm-burden models that incorporate specific biological features of human and snail hosts provide better estimates of Schistosoma diagnosis, transmission, and control.
Gurarie D; King CH; Yoon N; Li E
Parasit Vectors; 2016 Aug; 9(1):428. PubMed ID: 27492409
[TBL] [Abstract][Full Text] [Related]
20. Schistosomiasis Consortium for Operational Research and Evaluation: Mission Accomplished.
Bergquist NR
Am J Trop Med Hyg; 2020 Jul; 103(1_Suppl):1-4. PubMed ID: 32400351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
